Histologic features associated with metastatic potential in invasive adenocarcinomas of the lung

American Journal of Surgical Pathology

Volumn 37, Issue 7, 2013, Pages 1100-1108

  Xu, Lauren ^a   Tavora, Fabio ^b   Burke, Allen ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Messejana Heart and Lung Hospital ^*  (Brazil)

Author keywords

Histology; Lung adenocarcinoma; Metastasis; Micropapillary; Prognosis; Solid; Vascular invasion

Indexed keywords

ADENOCARCINOMA; AGED; ARTICLE; CELL NUCLEUS; FEMALE; HUMAN; LUNG TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MITOSIS; NUCLEOLUS; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; TUMOR INVASION;

ADENOCARCINOMA; AGED; CELL NUCLEOLUS; CELL NUCLEUS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOSIS; NEOPLASM INVASIVENESS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84880309633     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31827fcf04     Document Type: Article

References (14)

1. Travis WD, Brambilla E, Noguchi M, et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011; 6:244-285.
2. Xu L, Tavora F, Battafarano R, et al. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society. Am J Surg Pathol. 2012;36:273-282.
3. Travis WD, Brambilla E, Muller-Hermelink HK, et al. Pathology and Genetics. Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2004.
4. Sica G, Yoshizawa A, Sima CS, et al. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol. 2011;34: 1155-1162.
5. Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol. 2011;24:653-664.
6. Russell PA, Wainer Z, Wright GM, et al. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol. 2011;6:1496-1504.
7. Sterlacci W, Savic S, Schmid T, et al. Tissue-sparing application of the newly proposed IASLC/ATS/ERS classification of adenocarcinoma of the lung shows practical diagnostic and prognostic impact. Am J Clin Pathol. 2012;137:946-956.
8. Warth A, Muley T, Meister M, et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol. 2012;30:1438-1446.
9. Okudela K, Woo T, Mitsui H, et al. Proposal of an improved histological sub-typing system for lung adenocarcinoma - significant prognostic values for stage I disease. Int J Clin Exp Pathol. 2010;3: 348-366.
10. Nakazato Y, Minami Y, Kobayashi H, et al. Nuclear grading of primary pulmonary adenocarcinomas: correlation between nuclear size and prognosis. Cancer. 2010;116:2011-2019.
11. Minami Y, Matsuno Y, Iijima T, et al. Prognostication of smallsized primary pulmonary adenocarcinomas by histopathological and karyometric analysis. Lung Cancer. 2005;48:339-348.
12. Kadota K, Suzuki K, Kachala SS, et al. A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma. Mod Pathol. 2012; 25:1117-1127.
13. Bréchot JM, Chevret S, Charpentier MC, et al. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival. Cancer. 1996;78:2111-2118.
14. Kato T, Ishikawa K, Aragaki M, et al. Angiolymphatic invasion exerts a strong impact on surgical outcomes for stage I lung adenocarcinoma, but not non-adenocarcinoma. Lung Cancer. 2012;77:394-400.